Search
for
Sort by
Research 331–360 of 520
- Ophthalmologic Comorbidities in Alopecia Areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- Pathological sequelae of long-haul COVID
- Long-Term Effects of COVID-19
- Alopecia Areata: Treatment of Today and Tomorrow
- The Human Skin Microbiome in Selected Cutaneous Diseases
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- A Case of Frontal Fibrosing Alopecia in a Patient with Primary Biliary Cirrhosis and Polymyalgia Rheumatica
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Vitiligo and Its Mimics in Childhood: A Diagnostic Framework for Hypopigmented Disorders
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Treatments for alopecia areata: a network meta-analysis
- Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Alopecia areata − animal models
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Alopecia Areata after COVID-19 Vaccines
- Remission of Alopecia Universalis Following Successful Clinical Islet Transplantation
- Attending persistent T cell activation in alopecia areata : A therapeutic option
- Assessment of scalp hair survivin in patients with premature greying of hair
- Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Alopecia Areata